 |
|
 |
 |
| |
News -> July, 2000 News
After beginning as a coalition to work together for a united goal, the Sinus
& Allergy Health Partnership has evolved over 2 years since inception to
become a recognizable name within the specialty of otolaryngology. Three
societies formulated and participate: the American Rhinologic Society, the
American Academy of Otolaryngic Allergy, and the American Academy of
Otolaryngology-Head and Neck Surgery. Conceived as a concept to educate
otolaryngologists, primary care physicians and medical carriers, the
PartnershipÕs mission is to support the fact that ENT physicians are the
NOSE doctors. The Partnership is also working with the American Academy of
Facial Plastic and Reconstructive Surgery.
At the Spring Board of Governors meeting, the Steering Committee of the Sinus
and Allergy Health Partnership consisting of Drs. James Denneny, Michael
Benninger, Ivor Emanuel, James Hadley, David Osguthorpe, and James
Stankiewicz met to discuss strategy for the forthcoming years. Leadership
members of the sponsoring societies were invited including Dr. John Campbell,
President of the AAO-HNS, Dr. Charles Gross, President of the ARS, and Dr.
Jennifer Derebery, President of the AAOA. The purpose was to review the
mission of the partnership and examine the one-year, two-year and five-year
long-range plans. While the Partnership has had an immense success after its
debut in garnering resources from pharmaceutical and similar corporations, the
leadership desired to continue to offer benefits to the otolaryngic community.
Research has been incorporated into the mission statement.
Based on a consensus of the Steering Committee, the new mission statement for
the Sinus and Allergy Health Partnership is "To promote public and physician
education, to further quality medical care, and to facilitate development of
new knowledge of rhinosinusitis, allergic rhinitis, and related disorders
through the unique expertise of otolaryngologists."
The goals were expanded to include three areas: 1. Pubic and physician
education, 2. Assure quality care of Rhinologic problems, 3. Facilitate the
development of new knowledge. The latter goal will stimulate research within
otolaryngology via educational grants donated to the Partnership.
One of the goals of the Partnership was to establish proper guidelines not
only for treatment of Rhinosinusitis, but also for Allergic Rhinitis. The
first goal has been completed with the upcoming publication of a "white paper"
on the Guidelines for Treatment of Acute Bacterial Rhinosinusitis. Dr. Jack
Anon guided this task to completion. The taskforce was comprised of experts in
sinus disease, allergic rhinitis, infectious disease, pharmacology,
pediatrics, family practice and internal medicine with the participation of
representatives from the Centers for Disease Control and the Federal Drug
Administration. A new therapeutic formula was developed for treatment of mild,
moderate and persistent disease based on antibiotic efficacy. The "white paper"
will be available as a supplement to Otolaryngology Head and Neck Surgery in
July 2000. The partnership is extremely proud of this work, which will become
a significant contribution to the literature. The next project will be to
establish a similar guideline on the treatments of allergic rhinitis.
Other news: The Partnership has been certified as a non-profit 501C(6)
organization in the District of Columbia and has established its By Laws
for ratification. This final step solidifies the Partnership and will allow
future progress.
The Professor of Day Program is still achieving excellent reviews. This
program brings otolaryngologist experts into Family Practice residency
programs to teach the full scope of Rhinologic and other otolaryngologic
disorders. Those society members willing to participate in this program should
contact the SAHP office for information. We are also planning on incorporating
a revised version of a video on Sinusitis originally produced by Drs. David
Kennedy and Robert Meyers.
The Distinguished lecture remains active to educate the primary care community
about the scope and expertise of otolaryngologists especially as the nose
experts. This program is open to all members, and information about this
program and its slide series can be obtained form the administrative office.
The administrative office has moved to newer quarters in downtown Washington.
The new address is: Sinus & Allergy Health Partnership 1990 M Street, NW
Suite 680 Washington, DC 20036. Please contact Joe Fox (202-955-5010) or any
of the Steering Committee Members.
James A. Hadley, MD
Rochester, New York
|
|
|
|
|
